Nomura Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-86,624
| Closed | -$392K | – | 1505 |
|
|
2024
Q1 | $392K | Hold |
86,624
| – | – | ﹤0.01% | 852 |
|
|
2023
Q4 | $495K | Hold |
86,624
| – | – | ﹤0.01% | 849 |
|
|
2023
Q3 | $398K | Hold |
86,624
| – | – | ﹤0.01% | 863 |
|
|
2023
Q2 | $560K | Hold |
86,624
| – | – | ﹤0.01% | 851 |
|
|
2023
Q1 | $653K | Hold |
86,624
| – | – | ﹤0.01% | 836 |
|
|
2022
Q4 | $878K | Sell |
86,624
-8,938
| -9% | -$90.5K | 0.01% | 817 |
|
|
2022
Q3 | $945K | Hold |
95,562
| – | – | 0.01% | 796 |
|
|
2022
Q2 | $1.02M | Buy |
95,562
+40,732
| +74% | +$434K | 0.01% | 811 |
|
|
2022
Q1 | $535K | Hold |
54,830
| – | – | ﹤0.01% | 887 |
|
|
2021
Q4 | $784K | Buy |
+54,830
| New | +$784K | ﹤0.01% | 875 |
|